AbbVie Inc. Participating Securities, Distributed and Undistributed Earnings (Loss), Basic
AbbVie Inc. (ABBV) reported Participating Securities, Distributed and Undistributed Earnings (Loss), Basic of $12.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Earnings Per Share
us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic · last filed 2026-08-03
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for the quarter ending 2026-06-30 was $12.00M, a 20.00% increase year-over-year.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for the quarter ending 2026-03-31 was $10.00M, a 0.00% change year-over-year.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for the quarter ending 2025-12-31 was $10.00M, a 0.00% change year-over-year.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for the quarter ending 2025-09-30 was $10.00M, a 0.00% change year-over-year.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for fiscal 2025 was $40.00M, a 0.00% change from fiscal 2024.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for fiscal 2024 was $40.00M, a 6.98% decline from fiscal 2023.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for fiscal 2023 was $43.00M, a 20.37% decline from fiscal 2022.
- AbbVie Inc. participating securities, distributed and undistributed earnings (loss), basic for fiscal 2022 was $54.00M, a 27.03% decline from fiscal 2021.
| Period end | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic 3 month | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic 6 month | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic 9 month | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.00M 10-Q · filed 2026-08-03 | $20.00M 10-Q · filed 2026-08-03 | $32.00M derived: sum of 3 quarters · filed 2026-08-03 | $42.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $10.00M 10-Q · filed 2026-05-08 | $20.00M derived: sum of 2 quarters · filed 2026-05-08 | $30.00M derived: sum of 3 quarters · filed 2026-05-08 | $40.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $20.00M derived: sum of 2 quarters · filed 2026-02-20 | $30.00M derived: sum of 3 quarters · filed 2026-08-03 | $40.00M 10-K · filed 2026-02-20 |
| 2025-09-30 | $10.00M 10-Q · filed 2025-11-04 | $20.00M derived: sum of 2 quarters · filed 2026-08-03 | $30.00M 10-Q · filed 2025-11-04 | $40.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $10.00M 10-Q · filed 2026-08-03 | $20.00M 10-Q · filed 2026-08-03 | $30.00M derived: sum of 3 quarters · filed 2026-08-03 | $40.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $10.00M 10-Q · filed 2026-05-08 | $20.00M derived: sum of 2 quarters · filed 2026-05-08 | $30.00M derived: sum of 3 quarters · filed 2026-05-08 | $40.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $20.00M derived: sum of 2 quarters · filed 2026-02-20 | $30.00M derived: sum of 3 quarters · filed 2026-02-20 | $40.00M 10-K · filed 2026-02-20 |
| 2024-09-30 | $10.00M 10-Q · filed 2025-11-04 | $20.00M derived: sum of 2 quarters · filed 2025-11-04 | $30.00M 10-Q · filed 2025-11-04 | $41.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $10.00M 10-Q · filed 2025-08-04 | $20.00M 10-Q · filed 2025-08-04 | $31.00M derived: sum of 3 quarters · filed 2026-02-20 | $42.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $10.00M 10-Q · filed 2025-05-09 | $21.00M derived: sum of 2 quarters · filed 2026-02-20 | $32.00M derived: sum of 3 quarters · filed 2026-02-20 | $43.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $22.00M derived: sum of 2 quarters · filed 2026-02-20 | $33.00M derived: sum of 3 quarters · filed 2026-02-20 | $43.00M 10-K · filed 2026-02-20 |
| 2023-09-30 | $11.00M 10-Q · filed 2024-11-04 | $22.00M derived: sum of 2 quarters · filed 2024-11-04 | $32.00M 10-Q · filed 2024-11-04 | $44.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $11.00M 10-Q · filed 2024-08-07 | $22.00M 10-Q · filed 2024-08-07 | $33.00M derived: sum of 3 quarters · filed 2025-02-14 | $51.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $11.00M 10-Q · filed 2024-05-03 | $22.00M derived: sum of 2 quarters · filed 2025-02-14 | $40.00M derived: sum of 3 quarters · filed 2025-02-14 | $51.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $29.00M derived: sum of 2 quarters · filed 2025-02-14 | $40.00M derived: sum of 3 quarters · filed 2025-02-14 | $54.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $18.00M 10-Q · filed 2023-11-06 | $29.00M derived: sum of 2 quarters · filed 2023-11-06 | $43.00M 10-Q · filed 2023-11-06 | $72.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $11.00M 10-Q · filed 2023-08-07 | $26.00M 10-Q · filed 2023-08-07 | $54.00M derived: sum of 3 quarters · filed 2024-02-20 | $75.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $22.00M 10-Q · filed 2023-05-05 | $43.00M derived: sum of 2 quarters · filed 2024-02-20 | $64.00M derived: sum of 3 quarters · filed 2024-02-20 | $81.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $42.00M derived: sum of 2 quarters · filed 2024-02-20 | $59.00M derived: sum of 3 quarters · filed 2024-02-20 | $74.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $21.00M 10-Q · filed 2022-11-04 | $38.00M derived: sum of 2 quarters · filed 2022-11-04 | $53.00M 10-Q · filed 2022-11-04 | $78.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $17.00M 10-Q · filed 2022-08-04 | $34.00M 10-Q · filed 2022-08-04 | $57.00M derived: sum of 3 quarters · filed 2023-02-17 | $74.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $24.00M 10-Q · filed 2022-05-06 | $40.00M derived: sum of 2 quarters · filed 2023-02-17 | $57.00M derived: sum of 3 quarters · filed 2023-02-17 | $75.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $33.00M derived: sum of 2 quarters · filed 2023-02-17 | $51.00M derived: sum of 3 quarters · filed 2023-02-17 | $60.00M 10-K · filed 2023-02-17 |
| 2020-09-30 | $17.00M 10-Q · filed 2021-11-02 | $35.00M derived: sum of 2 quarters · filed 2021-11-02 | $44.00M 10-Q · filed 2021-11-02 | $62.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $18.00M 10-Q · filed 2021-08-02 | $28.00M 10-Q · filed 2021-08-02 | $45.00M derived: sum of 3 quarters · filed 2022-02-18 | $55.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $14.00M 10-Q · filed 2021-05-07 | $27.00M derived: sum of 2 quarters · filed 2022-02-18 | $37.00M derived: sum of 3 quarters · filed 2022-02-18 | $45.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $23.00M derived: sum of 2 quarters · filed 2022-02-18 | $31.00M derived: sum of 3 quarters · filed 2022-02-18 | $40.00M 10-K · filed 2022-02-18 |
| 2019-09-30 | $10.00M 10-Q · filed 2020-11-04 | $18.00M derived: sum of 2 quarters · filed 2020-11-04 | $27.00M 10-Q · filed 2020-11-04 | $26.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $8.00M 10-Q · filed 2020-08-04 | $17.00M 10-Q · filed 2020-08-04 | $16.00M derived: sum of 3 quarters · filed 2021-02-19 | $28.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $12.00M 10-Q · filed 2020-05-08 | $8.00M derived: sum of 2 quarters · filed 2021-02-19 | $20.00M derived: sum of 3 quarters · filed 2021-02-19 | $30.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $8.00M derived: sum of 2 quarters · filed 2021-02-19 | $18.00M derived: sum of 3 quarters · filed 2021-02-19 | $30.00M 10-K · filed 2021-02-19 |
| 2018-09-30 | $12.00M 10-Q · filed 2019-11-06 | $22.00M derived: sum of 2 quarters · filed 2019-11-06 | $34.00M 10-Q · filed 2019-11-06 | $34.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $10.00M 10-Q · filed 2019-08-05 | $22.00M 10-Q · filed 2019-08-05 | $22.00M derived: sum of 3 quarters · filed 2020-02-21 | $30.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $12.00M 10-Q · filed 2019-05-03 | $12.00M derived: sum of 2 quarters · filed 2020-02-21 | $20.00M derived: sum of 3 quarters · filed 2020-02-21 | $29.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $8.00M derived: sum of 2 quarters · filed 2020-02-21 | $17.00M derived: sum of 3 quarters · filed 2020-02-21 | $26.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $8.00M 10-Q · filed 2018-11-07 | $17.00M derived: sum of 2 quarters · filed 2018-11-07 | $26.00M 10-Q · filed 2018-11-07 | $33.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $9.00M 10-Q · filed 2018-08-07 | $18.00M 10-Q · filed 2018-08-07 | $25.00M derived: sum of 3 quarters · filed 2019-02-27 | $33.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $9.00M 10-Q · filed 2018-05-04 | $16.00M derived: sum of 2 quarters · filed 2019-02-27 | $24.00M derived: sum of 3 quarters · filed 2019-02-27 | $32.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $15.00M derived: sum of 2 quarters · filed 2019-02-27 | $23.00M derived: sum of 3 quarters · filed 2019-02-27 | $30.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $8.00M 10-Q · filed 2017-11-07 | $16.00M derived: sum of 2 quarters · filed 2017-11-07 | $23.00M 10-Q · filed 2017-11-07 | $31.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $8.00M 10-Q · filed 2017-08-07 | $15.00M 10-Q · filed 2017-08-07 | $23.00M derived: sum of 3 quarters · filed 2018-02-16 | $30.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $7.00M 10-Q · filed 2017-05-05 | $15.00M derived: sum of 2 quarters · filed 2018-02-16 | $22.00M derived: sum of 3 quarters · filed 2018-02-16 | |
| 2015-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $15.00M derived: sum of 2 quarters · filed 2018-02-16 | $26.00M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $7.00M 10-Q · filed 2016-11-07 | $18.00M 10-Q · filed 2016-11-07 | ||
| 2014-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$2.00M derived: sum of 2 quarters · filed 2017-02-17 | $9.00M 10-K · filed 2017-02-17 | |
| 2014-09-30 | $3.00M 10-Q · filed 2015-11-06 | $14.00M 10-Q · filed 2015-11-06 | ||
| 2013-12-31 | $26.00M 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |